ICOSLG Antikörper (Biotin)
Kurzübersicht für ICOSLG Antikörper (Biotin) (ABIN610255)
Target
Alle ICOSLG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Recombinant CD275 in EIA. It does not block the interaction between recombinant CD278 and CD275.
-
Aufreinigung
- Purified
-
Immunogen
- Human Raji cells, recombinant human CD275-muIg.
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 5 % Glycerol, 0.2 % BSA, 0.04 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Andere Bezeichnung
- ICOSLG / ICOSL / ICOS Ligand
-
Hintergrund
-
Name/Gene ID: ICOSLG
Synonyms: ICOSLG, B7RP1, B7 homolog 2, B7 homologue 2, B7-H2, B7H2, B7RP-1, CD275 antigen, ICOS ligand, GL50, ICOS-L, ICOSL, KIAA0653, B7-like protein Gl50, B7-related protein 1, CD275, LICOS -
Gen-ID
- 23308
-
UniProt
- O75144
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-